Hookworms presenting in New Zealand
Burton, J.
New Zealand Medical Journal 107(971): 42
1994
ISSN/ISBN: 0028-8446 PMID: 8302505 Document Number: 433203
A case of hookworm infection in a 64-year-old woman who had spent a year in Mexico before coming to New Zealand is reported. Her condition progressively worsened as the correct diagnosis was not made for 3 years in spite of numerous investigations and changes of medication.
Document emailed within 1 workday
Related Documents
Little, M.D.; Beaver, P.C. 1989: Hookworms then American Journal of Tropical Medicine and Hygiene 41(3 Suppl): 35-37Azariah, S.; Perkins, N. 2007: Risk factors and characteristics of patients with gonorrhoea presenting to Auckland Sexual Health Service, New Zealand New Zealand Medical Journal 120(1252): U2491
Yang Dong, C. 2016: The uses of mental health telephone counselling services for Chinese speaking people in new Zealand: demographics, presenting problems, outcome and evaluation of the calls New Zealand Medical Journal 129(1441): 68-77
Stoltzfus, R.J.; Chwaya, H.M.; Tielsch, J.M.; Schulze, K.J.; Albonico, M.; Savioli, L. 1997: Epidemiology of iron deficiency anemia in Zanzibari schoolchildren: the importance of hookworms American Journal of Clinical Nutrition 65(1): 153-159
Azariah, S. 2005: Is syphilis resurgent in New Zealand in the 21st century? a case series of infectious syphilis presenting to the Auckland Sexual Health Service New Zealand Medical Journal 118(1211): U1349
Nwosu, A.B. 1981: Human neonatal infections with hookworms in an endemic area of Southern Nigeria. A possible transmammary route Tropical and Geographical Medicine 33(2): 105-111
McCoy, K.L.; Kendrick, L.; Chused, T.M. 1986: Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice Journal of Immunology 136(4): 1217-1222
Schep, L.J.; Slaughter, R.J.; Temple, W.A. 2011: Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre New Zealand Medical Journal 124(1347): 99-101
Garrett, J.; Chen, B.; Taylor, D.Robin. 2009: A survey of respiratory and sleep services in New Zealand undertaken by the Thoracic Society of Australia and New Zealand (TSANZ) New Zealand medical journal 122(1289): 10-23
Rigby, R.J.; Rozzo, S.J.; Boyle, J.J.; Lewis, M.; Kotzin, B.L.; Vyse, T.J. 2004: New loci from New Zealand Black and New Zealand White mice on chromosomes 4 and 12 contribute to lupus-like disease in the context of BALB/c Journal of Immunology 172(7): 4609-4617
Barnett, J.R. 1991: Where have all the doctors gone? Changes in the geographic distribution of general practitioners in New Zealand since 1975 (3): New Zealand and foreign medical graduates compared New Zealand Medical Journal 104(918): 358-360
Wesley, A.W.; Asher, M.I.; Gillies, J.D.; Pattemore, P.K.; Kerr, A.; Hewitt, C. 1996: Proposals for standards of cystic fibrosis management in New Zealand. A position statement by the Respiratory Committee of the Paediatric Society of New Zealand New Zealand Medical Journal 109(1020): 140-141
Conde, C.; Weller, S.; Gilfillan, S.; Marcellin, L.; Martin, T.; Pasquali, J.L. 1998: Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice Journal of Immunology 161(12): 7023-7030
Elliott, J.M.; Wang, T.Kai.Ming.; Gamble, G.D.; Williams, M.Ja.; Matsis, P.; Troughton, R.; Hamer, A.; Devlin, G.; Mann, S.; Richards, M.; French, J.K.; White, H.D.; Ellis, C.J. 2017: A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012 New Zealand Medical Journal 130(1453): 17-28
Ohsugi, Y.; Gershwin, M.E.; Ahmed, A.; Skelly, R.R.; Milich, D.R. 1982: Studies of congenitally immunologic mutant New Zealand mice. VI. Spontaneous and induced autoantibodies to red cells and DNA occur in New Zealand X-linked immunodeficient (Xid) mice without phenotypic alternations of the Xid gene or generalized polyclonal B cell activation Journal of Immunology 128(5): 2220-2227
Fitzjohn, J.; Wilkinson, T.; Gill, D.; Mulder, R. 2003: The demographic characteristics of New Zealand medical students: the New Zealand Wellbeing, Intentions, Debt and Experiences (WIDE) Survey of Medical Students 2001 study New Zealand medical journal 116(1183): U626
Carlsen, N.L. 1996: Neuroblastomas presenting in the first year of life: epidemiological differences from those presenting at older ages Cancer Detection and Prevention 20(3): 251-261
Zahid, M.; Khan, A.H.; Yunus, Z.M.; Chen, B.C.; Steinmann, B.; Johannes, H.; Afroze, B. 2019: Inherited metabolic disorders presenting as hypoxic ischaemic encephalopathy: a case series of patients presenting at a tertiary care hospital in Pakistan JPMA. Journal of the Pakistan Medical Association 69(3): 432-436
Gershwin, M.E.; Castles, J.J.; Erickson, K.; Ahmed, A. 1979: Studies of congenitally immunologic mutant New Zealand mice. II. Absence of T cell progenitor populations and B cell defects of congenitally athymic (nude) New Zealand Black (NZB) mice Journal of Immunology 122(5): 2020-2025
Child, N.; Barber, P.Alan.; Fink, J.; Jones, S.; Voges, K.; Vivian, M. 2011: New Zealand National Acute Stroke Services Audit 2009: organisation of acute stroke services in New Zealand New Zealand Medical Journal 124(1340): 13-20